Vigonvita Life Sciences Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
351
- Stock Symbol
-
02630
- Share Price
-
$9.26
- (As of Friday Closing)
Vigonvita Life Sciences General Information
Description
Vigonvita Life Sciences Co Ltd biopharmaceutical company. It is focused on innovation driven biopharmaceutical development, with a strategic emphasis on addressing unmet clinical needs in the treatment of neuropsychiatric, infectious, and andrological diseases. The company's core Products include LV232, anti-depression drug candidate, VV913: a novel investigational drug candidate for premature ejaculation and, VV116: an oral nucleoside analog with broad-spectrum antiviral potential. The company's operations are located in the PRC and Uzbekistan. Revenue is generated from the out-licensing and the sales of its pharmaceutical products.
Contact Information
Website
www.vigonvita.cnCorporate Office
- 8th Floor, Building A
- No. 108 Yuxin Road
- Suzhou, Jiangsu 215021
- China
Corporate Office
- 8th Floor, Building A
- No. 108 Yuxin Road
- Suzhou, Jiangsu 215021
- China
Vigonvita Life Sciences Timeline
Vigonvita Life Sciences Stock Performance
As of 13-Nov-2026, Vigonvita Life Sciences’s stock price is $9.26. Its current market cap is $1.54B with 167M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $9.26 | $9.56 | $6.63 - $17.26 | $1.54B | 167M | 114K | -$0.29 |
Vigonvita Life Sciences Financials Summary
As of 30-Jun-2026, Vigonvita Life Sciences has a trailing 12-month revenue of $31M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,375,194 | 1,822,910 | ||
| Revenue | 31,049 | 14,197 | 1,649 | 28,220 |
| EBITDA | (42,029) | (42,436) | (23,492) | 4,053 |
| Net Income | (43,556) | (49,465) | (29,462) | 1,709 |
| Total Assets | 181,666 | 184,276 | 99,445 | 95,406 |
| Total Debt | 126,351 | 92,411 | 57,047 | 45,288 |
Vigonvita Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Vigonvita Life Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Vigonvita Life Sciences Patents
Vigonvita Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026228718-A1 | Tetrahydrobenzothiazole derivative, pharmaceutical composition comprising same, and uses thereof | Pending | 30-Apr-2025 | ||
| WO-2026219142-A1 | Crystal form of nucleoside analog, preparation method therefor, pharmaceutical composition thereof and use thereof | Pending | 16-Apr-2025 | ||
| WO-2026219162-A1 | Use of nucleoside analog in preparation of drug for treating rabies virus infections | Pending | 14-Apr-2025 | ||
| WO-2026158267-A1 | Use of nucleoside analog in preparation of drug for treating or preventing diseases caused by paramyxoviridae virus infections | Pending | 21-Jan-2025 | ||
| WO-2026017114-A1 | Use of phenylpyrimidinone compound | Pending | 17-Jul-2024 |
Vigonvita Life Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Vigonvita Life Sciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Vigonvita Life Sciences FAQs
-
When was Vigonvita Life Sciences founded?
Vigonvita Life Sciences was founded in 2013.
-
Where is Vigonvita Life Sciences headquartered?
Vigonvita Life Sciences is headquartered in Suzhou, China.
-
What is the size of Vigonvita Life Sciences?
Vigonvita Life Sciences has 351 total employees.
-
What industry is Vigonvita Life Sciences in?
Vigonvita Life Sciences’s primary industry is Drug Discovery.
-
Is Vigonvita Life Sciences a private or public company?
Vigonvita Life Sciences is a Public company.
-
What is Vigonvita Life Sciences’s stock symbol?
The ticker symbol for Vigonvita Life Sciences is 02630.
-
What is the current stock price of Vigonvita Life Sciences?
As of 13-Nov-2026 the stock price of Vigonvita Life Sciences is $9.26.
-
What is the current market cap of Vigonvita Life Sciences?
The current market capitalization of Vigonvita Life Sciences is $1.54B.
-
What is Vigonvita Life Sciences’s current revenue?
The trailing twelve month revenue for Vigonvita Life Sciences is $31M.
-
What is Vigonvita Life Sciences’s annual earnings per share (EPS)?
Vigonvita Life Sciences’s EPS for 12 months was -$0.29.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
